Bashing, Buying and BuildingOf course bashers would arrive on good news ...particularly if their whole game is based on day trading and penny flipping which has CLEARLY been the case for ScreenPro. With covid testing continuing, significant 2021 financials on the way and now some serious direction from management related to Add Biomedical it SHOULD be much more challenging to keep a mid to longterm lid on the sp.
The buying of shares by insiders, something many on this board have been asking for, is another clear signal that management has a longterm vision. Not only that but the shares purchased by insiders today represents about 30% of all the shares that exchanged hands today. Also telling is that Michael Yeungs' shares were purchased at $.065.
Finally, and while it's not all roses yet, Lena Kozovski is clearly the most transparent of the three CEOs ScreenPro has been guided by in its early iteration as a public company. She stated her goal is to build the company and in doing so, shareholder value. The action(s) today represent the beginning of that focus and expectation. One can hope that April will be the beginning of not only a positive foray into the world of cancer diagnostics but a move by the sp that represents this and a more appropriate valuation based on revenues and profits.
GLTE!!!